Hemodynamic Monitoring Systems Market Opportunities, Challenges And Major Players Edwards Lifescience, LiDCO Group, PULSION Medical Systems SE, Cheetah Medical, ICU Medical

Hemodynamics monitoring systems refer to the observation units that assists in measurement of pressure, flow, and oxygenation of blood within the cardiovascular system. Hemodynamic monitoring can detect small changes that determines the changes in heart functions early by testing samples of blood from deep inside the body. This type of monitoring is usually employed in critically ill patients that require continuous assessment of their cardiovascular systems to manage complex medical conditions.

Moreover, hemodynamics monitoring is also used to evaluate the patient’s immediate responses to treatments such as mechanical support, cardiovascular surgeries, and drug delivery. These systems are used in cardiac catheterization lab or interventional labs for monitoring arterial blood pressure, central venous pressure, and other parameters of patients. These systems are linked to catheterization lab reporting systems, inventory management, and cardiovascular information system (CVIS) for gathering relevant data and presenting trends of the observations for improving clinical outcomes. Rising incidence of cardiovascular diseases is one of the major factors driving growth of the global hemodynamics monitoring systems market. For instance, according to World Health Organization (WHO), 17.5 million people die each year from CVDs. Low-income and middle-income economies account for over 75% of CVD deaths. Furthermore, heart attacks and strokes are responsible for 80% of all CVD deaths.

The global hemodynamics monitoring systems market is estimated to be valued at US$ 929.1 million in 2017 and is expected to witness a robust CAGR of 5.5% over the forecast period (2017 - 2025).

Request A Sample Copy:
https://www.coherentmarketinsights.com/insight/request-sample/1070

Factors such as increasing aging population with a higher risk of developing chronic diseases, technological advancements in hemodynamic systems, and increasing prevalence of chronic diseases mainly CVDs are expected to drive growth of the hemodynamic monitoring systems market throughout the forecast period. According to Center for Disease Control and Prevention, in 2015, around 28.4 million people were diagnosed with heart diseases in the U.S. alone. This number is expected to rise in the near future, owing to changes in lifestyle and others. Demand for minimally invasive and non-invasive technologies that measure cardiac output, stroke volume, and other parameters such as oxygen concentration and others is expected to boost demand for these systems. In the recent past, hemodynamic monitoring has evolved significantly from invasiveness to minimum or no invasiveness and from intermittent to continuous and real-time measurements of hemodynamic variables.

For instance, according to the National Center for Biotechnology Information 2016, preference for minimally invasive procedures and robotic assisted medical procedures has increased by 66% in 2013 as compared to that in the 2000. Non-invasive systems are increasingly been used in high-risk surgical patients. Continuous improvements in terms systems is expected to aid in growth of the segment. In June 2016, Cheetah Medical introduced Starling SV non-invasive hemodynamic system after receiving FDA clearance and CE marking that predicts IV fluids responsiveness, similar to other invasive modalities. However, risks associated with invasive hemodynamic monitoring, which is still practiced, are significantly greater and is expected to hinder the market growth.

North America was the dominant region in the global hemodynamics monitoring systems market in 2016. This is attributed to rapid development of innovative products that help in conducting hemodynamic monitoring effectively. For instance, in February 2018, Getinge—a leading global provider of innovative medical technology—received FDA 510(k) clearance for PulsioFlex Monitoring System and PiCCO Module, which is used for hemodynamic management of critically ill patients. Moreover, rising incidence of cardiovascular diseases is also boosting growth of the market in the region. According to the American Heart Association, 2017, around 209,000 patients in the U.S. were admitted in the ICU suffering from cardiac arrest and their heart activity was consistently monitored.

Asia Pacific market is expected to witness growth over the forecast period, owing to increasing collaborations by companies in the region, in order to enhance their product offerings and market share. For instance, in 2015, LiDCO—a hemodynamic monitoring company—collaborated with Fieldman Medical to distribute the LiDCO products such as LiDCOrapid and LiDCOplus in the countries of Asia Pacific. The agreement is expected to create a lucrative opportunity for manufacturers to expand their hemodynamic monitoring solutions portfolio and provide efficient outcomes to patients during surgical procedures.

Market players are focusing on developing innovative products to maintain leading position in the global hemodynamics monitoring systems market

Key players are focusing on developing novel and innovative products, to sustain in the hemodynamics monitoring systems market. For instance, in March 2017, Teleflex announced 510(k) clearance by the Food and Drug Administration and both the U.S. and international commercial launch of the Twin-Pass Torque Dual Access Catheter. Moreover, in May 2016, Deltex Medical Group Plc introduced TruFlow in the U.K., which is wider beam, single patient disposable probe, the reconfigured probe tip design that creates a wider ultrasound beam at the focal point in the aorta.

Key players operating the global hemodynamics monitoring systems market include Edwards Lifescience Corporation, LiDCO Group, Plc, PULSION Medical Systems SE, Cheetah Medical, Inc. ICU Medical, Inc., Deltex Medical Group Plc, and Teleflex, Inc.

Download the PDF brochure:
https://www.coherentmarketinsights.com/insight/request-pdf/1070

About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:
Mr.Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email:sales@coherentmarketinsights.com

This release was published on openPR.